Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-31

Clinical Trial Update: Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating cholecalciferol supplementation for anemia and mineral and bone disorder in chronic kidney disease patients on hemodialysis; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Takayuki Hamano | Conditions: Kidney Failure, Chronic, Anemia | Phase 4 | Status: COMPLETED